TG THERAPEUTICS, INC.: cashflow_financing
| Value | {"amount": 390914000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-06-30 |
| Status | current |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:14.432113+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0a213a1c-614a-410e-8e69-411cb76d9d95
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-26-025955Retrieved: 2026-08-19T09:42:14.432113+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/cashflow-financing/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0a213a1c-614a-410e-8e69-411cb76d9d95
History
- no predecessors — first report